NCT05016219View on ClinicalTrials.gov

Phase 2 - Rhythmic Light Therapy for Alzheimer's Disease Patients

NARecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

August 22, 2023

Primary Completion Date

July 31, 2026

Study Completion Date

July 31, 2027

Conditions
Mild Cognitive Impairment
Interventions
DEVICE

Circadian-Effective Light

Narrowband blue light

DEVICE

Rhythmic Light

40 hertz (Hz) flicker

DEVICE

Placebo Light

Narrowband red light

DEVICE

Placebo Rhythmic Light

Random flicker for placebo rhythmic effect

Trial Locations (2)

10029

RECRUITING

Icahn School of Medicine at Mount Sinai, New York

12204

RECRUITING

Light and Health Research Center, Menands

All Listed Sponsors
lead

Icahn School of Medicine at Mount Sinai

OTHER